trial

Assessment of the Effectiveness of the NECT Program

NCTId NCT03972735
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 120 (estimated)
Sponsored by Hospital Center Alpes-Isère
Primary completion 2022-09-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
120 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Single
Start
2020-02-10
Primary completion
2022-09-01
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Psychiatric interviewClinical, diagnostic and functional evaluationNeuropsychological assessmentNECT PROGRAM

Sponsors

Hospital Center Alpes-IsèreLead Sponsor
Hôpital le VinatierCollaborator
University Hospital, GrenobleCollaborator
Clinique du DauphinéCollaborator
CH Annecy GenevoisCollaborator
University Hospital, Clermont-FerrandCollaborator
Centre Hospitalier EsquirolCollaborator
Centre Hospitalier Universitaire de NiceCollaborator
CHS LE VALMONTCollaborator
University Hospital, CaenCollaborator
University Hospital, GenevaCollaborator
University Hospital, MontpellierCollaborator

Investigators

1
Julien JD DUBREUCQ, MDPrincipal Investigator

Sites

11 total
Annecy, FranceBron, FranceClermont-Ferrand, FranceGrenoble, FranceLimoges, FranceSeyssins, FranceValence, FranceCaen, FranceMontpellier, FranceNice, FranceGeneva, Switzerland

Facts & assertions

4 sourced
Enrollment
120
Phase
NA
Primary Completion Date
2022-09-01
Status
UNKNOWN
relationships
The graph out of here
drug
Psychiatric interview
drug
Clinical, diagnostic and functional evaluation
drug
Neuropsychological assessment
drug
NECT PROGRAM
drug
lead_sponsor
Hospital Center Alpes-Isère
company
collaborator
Hôpital le Vinatier
company
University Hospital, Grenoble
company
indication
Bipolar Disorder
indication
Borderline Personality Disorder
indication
Borderline Personality Disorder
indication
investigator
Julien JD DUBREUCQ, MD
person